Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoparathyroidism | 35 | 2024 | 136 | 11.730 |
Why?
|
Parathyroid Hormone | 34 | 2024 | 1789 | 3.800 |
Why?
|
Hypocalcemia | 11 | 2025 | 205 | 2.420 |
Why?
|
Parathyroid Glands | 7 | 2024 | 521 | 1.770 |
Why?
|
Calcium | 28 | 2024 | 5767 | 1.440 |
Why?
|
Hormone Replacement Therapy | 8 | 2021 | 753 | 1.220 |
Why?
|
Hyperparathyroidism, Primary | 6 | 2022 | 163 | 1.170 |
Why?
|
Receptors, Calcium-Sensing | 3 | 2025 | 320 | 1.000 |
Why?
|
Hypercalcemia | 5 | 2025 | 426 | 1.000 |
Why?
|
Diphtheria Toxin | 2 | 2017 | 253 | 0.990 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 7 | 2024 | 305 | 0.960 |
Why?
|
Hypercalciuria | 2 | 2017 | 31 | 0.960 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2017 | 103 | 0.920 |
Why?
|
Nephrocalcinosis | 1 | 2022 | 55 | 0.800 |
Why?
|
Phosphates | 7 | 2023 | 763 | 0.770 |
Why?
|
Vitamin D | 15 | 2023 | 3272 | 0.660 |
Why?
|
Hyperphosphatemia | 2 | 2017 | 38 | 0.660 |
Why?
|
Fibrous Dysplasia, Polyostotic | 3 | 2024 | 39 | 0.650 |
Why?
|
Parathyroidectomy | 4 | 2017 | 244 | 0.640 |
Why?
|
Calcitriol | 6 | 2024 | 299 | 0.640 |
Why?
|
Recombinant Proteins | 8 | 2021 | 6493 | 0.590 |
Why?
|
Databases, Genetic | 1 | 2025 | 1751 | 0.580 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1462 | 0.540 |
Why?
|
Naphthalenes | 1 | 2017 | 197 | 0.510 |
Why?
|
Databases as Topic | 1 | 2018 | 471 | 0.510 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 390 | 0.490 |
Why?
|
Receptors, Parathyroid Hormone | 5 | 1999 | 332 | 0.480 |
Why?
|
Hypophosphatemia, Familial | 2 | 2012 | 32 | 0.450 |
Why?
|
Osteogenesis Imperfecta | 1 | 2014 | 81 | 0.440 |
Why?
|
Hajdu-Cheney Syndrome | 1 | 2013 | 2 | 0.430 |
Why?
|
Editorial Policies | 1 | 2018 | 458 | 0.420 |
Why?
|
Osteoporosis | 4 | 2022 | 1582 | 0.410 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.400 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 90 | 0.400 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 35 | 0.400 |
Why?
|
Rickets | 1 | 2012 | 66 | 0.390 |
Why?
|
Fractures, Bone | 3 | 2023 | 2041 | 0.370 |
Why?
|
Calcium, Dietary | 4 | 2022 | 526 | 0.370 |
Why?
|
Fibroblast Growth Factors | 6 | 2023 | 871 | 0.360 |
Why?
|
Collagen Type I | 1 | 2014 | 615 | 0.360 |
Why?
|
Osteomalacia | 3 | 2008 | 60 | 0.360 |
Why?
|
Genes, Dominant | 3 | 2013 | 856 | 0.350 |
Why?
|
Bone and Bones | 7 | 2023 | 2554 | 0.340 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 244 | 0.330 |
Why?
|
Information Dissemination | 1 | 2018 | 1142 | 0.330 |
Why?
|
Gene Deletion | 2 | 2014 | 2666 | 0.310 |
Why?
|
Germ-Line Mutation | 2 | 2013 | 1884 | 0.280 |
Why?
|
Parathyroid Hormone-Related Protein | 3 | 2015 | 327 | 0.280 |
Why?
|
Nuclear Proteins | 3 | 2012 | 5783 | 0.280 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2022 | 1242 | 0.270 |
Why?
|
Mutation | 7 | 2025 | 30198 | 0.270 |
Why?
|
Pedigree | 7 | 2014 | 4526 | 0.260 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 57 | 0.260 |
Why?
|
Humans | 71 | 2025 | 765968 | 0.230 |
Why?
|
Fascioliasis | 2 | 2000 | 14 | 0.230 |
Why?
|
Fasciola hepatica | 2 | 2000 | 15 | 0.230 |
Why?
|
Transcription Factors | 4 | 2014 | 12131 | 0.220 |
Why?
|
Bone Density Conservation Agents | 2 | 2023 | 791 | 0.220 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2024 | 52 | 0.220 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18293 | 0.210 |
Why?
|
Amiloride | 1 | 2022 | 115 | 0.200 |
Why?
|
Ovulation Induction | 1 | 2024 | 277 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2310 | 0.200 |
Why?
|
Homeostasis | 5 | 2023 | 3336 | 0.190 |
Why?
|
Hyperparathyroidism | 3 | 2018 | 337 | 0.190 |
Why?
|
Urolithiasis | 1 | 2022 | 123 | 0.180 |
Why?
|
Endocrine System Diseases | 1 | 2023 | 243 | 0.180 |
Why?
|
Adenoma | 1 | 2011 | 2152 | 0.170 |
Why?
|
Female | 36 | 2024 | 396112 | 0.170 |
Why?
|
Anthelmintics | 1 | 2000 | 83 | 0.170 |
Why?
|
Homozygote | 2 | 2015 | 1775 | 0.170 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2024 | 501 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 278 | 0.160 |
Why?
|
Male | 33 | 2024 | 363698 | 0.160 |
Why?
|
Adult | 20 | 2024 | 223044 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9550 | 0.150 |
Why?
|
Thyroidectomy | 3 | 2023 | 916 | 0.150 |
Why?
|
Chromogranins | 1 | 2019 | 161 | 0.150 |
Why?
|
Animals | 25 | 2024 | 168764 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2019 | 4108 | 0.140 |
Why?
|
Puberty, Precocious | 1 | 2019 | 163 | 0.140 |
Why?
|
Cholestasis | 1 | 2000 | 386 | 0.140 |
Why?
|
Osteoporotic Fractures | 1 | 2022 | 415 | 0.140 |
Why?
|
Brain | 1 | 2024 | 27171 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 195 | 0.140 |
Why?
|
Luminescent Agents | 1 | 2017 | 30 | 0.140 |
Why?
|
Neuralgia | 1 | 2024 | 625 | 0.140 |
Why?
|
Middle Aged | 20 | 2024 | 223009 | 0.130 |
Why?
|
Poisons | 1 | 2017 | 37 | 0.130 |
Why?
|
Glucuronidase | 1 | 2018 | 203 | 0.130 |
Why?
|
Kidney | 9 | 2023 | 7066 | 0.130 |
Why?
|
Hyponatremia | 1 | 2019 | 276 | 0.130 |
Why?
|
Depsipeptides | 1 | 2016 | 95 | 0.130 |
Why?
|
Bone Density | 3 | 2024 | 3491 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2015 | 2589 | 0.120 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 419 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2000 | 864 | 0.120 |
Why?
|
Mesenchymoma | 2 | 2008 | 50 | 0.120 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2014 | 20 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 65188 | 0.120 |
Why?
|
Authorship | 1 | 2018 | 288 | 0.120 |
Why?
|
Peer Review, Research | 1 | 2018 | 341 | 0.120 |
Why?
|
Genetic Variation | 2 | 2025 | 6610 | 0.120 |
Why?
|
Bradykinin | 1 | 1995 | 205 | 0.120 |
Why?
|
Acrylic Resins | 1 | 1995 | 131 | 0.110 |
Why?
|
Calcium Citrate | 1 | 2013 | 8 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13462 | 0.110 |
Why?
|
Uremia | 4 | 1996 | 202 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2012 | 17594 | 0.110 |
Why?
|
Mice | 9 | 2023 | 81819 | 0.110 |
Why?
|
Pseudohypoparathyroidism | 3 | 2019 | 87 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2008 | 1799 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13400 | 0.110 |
Why?
|
Spasm | 1 | 2013 | 131 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2018 | 12437 | 0.100 |
Why?
|
Lanthanum | 1 | 2012 | 30 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 605 | 0.100 |
Why?
|
HEK293 Cells | 3 | 2017 | 4260 | 0.100 |
Why?
|
Finger Phalanges | 1 | 2013 | 41 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 967 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2980 | 0.100 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 185 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4772 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 682 | 0.100 |
Why?
|
Polyamines | 1 | 2012 | 130 | 0.100 |
Why?
|
Aged | 10 | 2024 | 171117 | 0.090 |
Why?
|
Reference Values | 1 | 2018 | 4908 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 313 | 0.090 |
Why?
|
Chelating Agents | 1 | 2012 | 380 | 0.090 |
Why?
|
Heterozygote | 2 | 2019 | 2794 | 0.090 |
Why?
|
Family Health | 2 | 2012 | 1253 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3423 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3819 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 386 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2060 | 0.090 |
Why?
|
Tissue Extracts | 2 | 2008 | 139 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 2 | 2004 | 123 | 0.080 |
Why?
|
Genes, Recessive | 1 | 2012 | 624 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4392 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2412 | 0.080 |
Why?
|
Genetic Linkage | 2 | 2013 | 2341 | 0.080 |
Why?
|
Diphosphonates | 2 | 2023 | 625 | 0.080 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2008 | 36 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2018 | 3425 | 0.070 |
Why?
|
Xenopus laevis | 1 | 2012 | 964 | 0.070 |
Why?
|
Angiodysplasia | 1 | 2008 | 22 | 0.070 |
Why?
|
Hemangiopericytoma | 1 | 2008 | 71 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 1514 | 0.070 |
Why?
|
Jaw Neoplasms | 1 | 2008 | 71 | 0.070 |
Why?
|
Cell Lineage | 1 | 2017 | 2573 | 0.070 |
Why?
|
Oocytes | 1 | 2012 | 1169 | 0.070 |
Why?
|
Creatinine | 2 | 2023 | 1915 | 0.070 |
Why?
|
Adolescent | 6 | 2024 | 88835 | 0.070 |
Why?
|
Thigh | 1 | 2008 | 238 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2019 | 1740 | 0.070 |
Why?
|
Leg Ulcer | 1 | 2007 | 70 | 0.070 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2495 | 0.070 |
Why?
|
Models, Molecular | 2 | 2013 | 5379 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2371 | 0.060 |
Why?
|
Chickens | 1 | 2008 | 842 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1663 | 0.060 |
Why?
|
Nose Neoplasms | 1 | 2008 | 249 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3715 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1259 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8297 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12976 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7851 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4900 | 0.060 |
Why?
|
Calciphylaxis | 1 | 2007 | 130 | 0.060 |
Why?
|
COS Cells | 2 | 2015 | 1136 | 0.060 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 26 | 0.060 |
Why?
|
Sodium Fluoride | 1 | 2024 | 60 | 0.060 |
Why?
|
Foot | 1 | 2008 | 573 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2098 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4588 | 0.050 |
Why?
|
DNA | 2 | 2014 | 7202 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20659 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6309 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12807 | 0.050 |
Why?
|
Base Sequence | 4 | 2012 | 12403 | 0.050 |
Why?
|
Facial Bones | 1 | 2024 | 208 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2007 | 384 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2007 | 408 | 0.050 |
Why?
|
Young Adult | 3 | 2013 | 59889 | 0.050 |
Why?
|
Mice, Knockout | 1 | 1997 | 14448 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6919 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2018 | 59489 | 0.050 |
Why?
|
Alendronate | 1 | 2022 | 174 | 0.050 |
Why?
|
Neoplasms | 2 | 2008 | 22340 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15747 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2023 | 235 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4247 | 0.040 |
Why?
|
Renin | 1 | 2022 | 647 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2022 | 361 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 969 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 547 | 0.040 |
Why?
|
Sweden | 1 | 2022 | 1381 | 0.040 |
Why?
|
NAD | 1 | 2023 | 619 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 838 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2022 | 651 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22332 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1998 | 127 | 0.040 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 85 | 0.040 |
Why?
|
CHO Cells | 2 | 2016 | 1372 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10563 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 881 | 0.040 |
Why?
|
Republic of Korea | 1 | 2019 | 588 | 0.040 |
Why?
|
Imidazoles | 1 | 2023 | 1162 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1125 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2016 | 3750 | 0.040 |
Why?
|
Hypophosphatemia | 1 | 2018 | 92 | 0.030 |
Why?
|
Family | 1 | 2008 | 3209 | 0.030 |
Why?
|
Down-Regulation | 2 | 1995 | 2927 | 0.030 |
Why?
|
Cricetinae | 2 | 2016 | 2411 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2018 | 12768 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36532 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1998 | 326 | 0.030 |
Why?
|
Peptide Fragments | 2 | 1999 | 5125 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1707 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54802 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1180 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1441 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1529 | 0.030 |
Why?
|
Binding Sites | 2 | 2016 | 6001 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2018 | 870 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 41649 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 150 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 687 | 0.030 |
Why?
|
RANK Ligand | 1 | 2017 | 319 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1679 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9347 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1144 | 0.030 |
Why?
|
Cellulose | 1 | 1995 | 116 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2699 | 0.030 |
Why?
|
Cricetulus | 1 | 2016 | 805 | 0.030 |
Why?
|
Integrases | 1 | 2017 | 520 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 619 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 369 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 5995 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2910 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 774 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2410 | 0.030 |
Why?
|
Child | 3 | 2024 | 80564 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 1995 | 362 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1823 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 18973 | 0.030 |
Why?
|
Calcium Compounds | 1 | 2012 | 40 | 0.030 |
Why?
|
Skull | 1 | 2017 | 811 | 0.020 |
Why?
|
Mutagenesis | 1 | 2016 | 1228 | 0.020 |
Why?
|
United States | 2 | 2017 | 72903 | 0.020 |
Why?
|
Sulfones | 1 | 1995 | 447 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2564 | 0.020 |
Why?
|
Genetic Engineering | 1 | 1997 | 933 | 0.020 |
Why?
|
Kidney Calculi | 1 | 2016 | 457 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1143 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4165 | 0.020 |
Why?
|
Ligands | 1 | 1998 | 3273 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3424 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39193 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3051 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3946 | 0.020 |
Why?
|
Siblings | 1 | 2014 | 828 | 0.020 |
Why?
|
Signal Transduction | 3 | 2017 | 23601 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2016 | 804 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16721 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1194 | 0.020 |
Why?
|
Cataract | 1 | 2016 | 837 | 0.020 |
Why?
|
Ultrasonography | 2 | 2019 | 5993 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42500 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21480 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2022 | 81514 | 0.020 |
Why?
|
Rats | 4 | 1998 | 23707 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2012 | 901 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6547 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6897 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2745 | 0.020 |
Why?
|
Anaphylaxis | 1 | 1995 | 739 | 0.020 |
Why?
|
Polymers | 1 | 1995 | 1621 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3449 | 0.020 |
Why?
|
Rats, Wistar | 3 | 1996 | 1884 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5929 | 0.020 |
Why?
|
Pressure Ulcer | 1 | 2007 | 155 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10383 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4255 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2022 | 7425 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2535 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3312 | 0.010 |
Why?
|
Health Status | 1 | 2018 | 4080 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5020 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7562 | 0.010 |
Why?
|
Citrates | 1 | 2004 | 130 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9591 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14071 | 0.010 |
Why?
|
Cell Line | 2 | 2012 | 15543 | 0.010 |
Why?
|
Molecular Probes | 2 | 1995 | 307 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10808 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30260 | 0.010 |
Why?
|
Leg | 1 | 2007 | 1080 | 0.010 |
Why?
|
Opossums | 1 | 2001 | 104 | 0.010 |
Why?
|
Cholangiography | 1 | 2000 | 182 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9296 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 156 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2163 | 0.010 |
Why?
|
Bile Ducts | 1 | 2000 | 288 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8733 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11888 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15842 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 22223 | 0.010 |
Why?
|
Ischemia | 1 | 2007 | 1909 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 598 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1526 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1467 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 9649 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1292 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12056 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1433 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 945 | 0.010 |
Why?
|
Urine | 1 | 1995 | 360 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12509 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1995 | 1306 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6113 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5743 | 0.010 |
Why?
|
Blood | 1 | 1995 | 597 | 0.010 |
Why?
|
Haplotypes | 1 | 1998 | 2728 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4618 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7599 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12240 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 74840 | 0.000 |
Why?
|